Bladder Cancer
Urothelial carcinoma of the bladder, the most common urinary tract malignancy.
Arzneimittel für diese Erkrankung
Avelumab
CHEMBL3833373 · Antibody
Chlornaphazine
CHEMBL2107519 · Small molecule
Durvalumab
CHEMBL3301587 · Antibody
Enfortumab Vedotin
CHEMBL3301589 · Antibody drug conjugate
Epirubicin
CHEMBL417 · Small molecule
Epirubicin Hydrochloride
CHEMBL1200981 · Small molecule
Erdafitinib
CHEMBL3545376 · Small molecule
Hexaminolevulinate
CHEMBL1201784 · Small molecule
Hexaminolevulinate Hydrochloride
CHEMBL1201785 · Small molecule
Lapatinib
CHEMBL554 · Small molecule
Lisinopril
CHEMBL419213 · Small molecule
Mirabegron
CHEMBL2095212 · Small molecule
Mitomycin
CHEMBL105 · Small molecule
Nogapendekin Alfa Inbakicept
CHEMBL6068330 · Protein
Solifenacin
CHEMBL1734 · Small molecule
Tarlatamab
CHEMBL5095292 · Antibody
Technetium Medronate
CHEMBL2110576 · Small molecule
Teniposide
CHEMBL452231 · Small molecule
Thiotepa
CHEMBL671 · Small molecule
Tislelizumab
CHEMBL4297840 · Antibody
Valrubicin
CHEMBL1096885 · Small molecule
Vinblastine
CHEMBL159 · Small molecule
Vinblastine Sulfate
CHEMBL378544 · Small molecule
Vinflunine
CHEMBL2110725 · Small molecule
Vinflunine Ditartrate
CHEMBL2105629 · Small molecule